Pharmaceutical Medicine
100 mg Debiglip 100 SR Vildagliptin Sustained Release Tablets
Price on Request
Debiglip 100 SR contains 100 mg of Vildagliptin in a sustained-release formulation. It is a DPP-4 inhibitor prescribed to manage Type 2 Diabetes by boosting insulin release from the pancreas and reducing glucose production in the liver. The sustained-release version allows for once-daily dosing.
liketo,usa.uk.china.southkorea.russia.japan.singapore
liketo,usa.uk.china.southkorea.russia.japan.singapore
Composition
Strength 100 mg
Composition Vildagliptin
Pack Size 10*1*15 TABLETS
Brand DEBIGLIP-SR TABLETS 100MG
Usage Type 2 Diabetes
Prescription Type Prescription
Release Type Immediate Release
Shelf Life 36 months
Minimum order quantity: 50 Strip
Enquire About This Product
